APO RESEARCH · REPORT
Amoxicillin
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Product & engineering
Understand the product.
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Selected research
Industry Growth & Trends
Global Amoxicillin Industry Growth and Trends Forecast to 2032
Market perspective
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Amoxicillin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Amoxicillin market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amoxicillin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amoxicillin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Amoxicillin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Amoxicillin Market by Company
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Amoxicillin Segment by Type
Capsule
Tablet
Others
Amoxicillin Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Amoxicillin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amoxicillin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amoxicillin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amoxicillin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amoxicillin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Amoxicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Others
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Companies covered
- GSK
- Novartis
- Centrient Pharma
- Teva
- Mylan
- Cipla
- NCPC
- United Laboratories
- Sun Pharma
- CSPC
- LKPC
- Hikma
- Dr. Reddy
- HPGC
- Aurubindo
- Meiji Holdings
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Amoxicillin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Amoxicillin Sales Estimates and Forecasts (2021-2032)
- 1.3 Amoxicillin Market by Type
- 1.3.1 Capsule
- 1.3.2 Tablet
- 1.3.3 Others
- 1.4 Global Amoxicillin Market Size by Type
- 1.4.1 Global Amoxicillin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Amoxicillin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Amoxicillin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Amoxicillin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Amoxicillin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Amoxicillin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Amoxicillin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Amoxicillin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Amoxicillin Industry Trends
- 2.2 Amoxicillin Industry Drivers
- 2.3 Amoxicillin Industry Opportunities and Challenges
- 2.4 Amoxicillin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Amoxicillin Revenue (2021-2026)
- 3.2 Global Top Players by Amoxicillin Sales (2021-2026)
- 3.3 Global Top Players by Amoxicillin Price (2021-2026)
- 3.4 Global Amoxicillin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Amoxicillin Major Company Production Sites & Headquarters
- 3.6 Global Amoxicillin Company, Product Type & Application
- 3.7 Global Amoxicillin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Amoxicillin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Amoxicillin Players Market Share by Revenue in 2025
- 3.8.3 2025 Amoxicillin Tier 1, Tier 2, and Tier 3
4 Amoxicillin Regional Status and Outlook
- 4.1 Global Amoxicillin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Amoxicillin Historic Market Size by Region
- 4.2.1 Global Amoxicillin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Amoxicillin Sales in Value by Region (2021-2026)
- 4.2.3 Global Amoxicillin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Amoxicillin Forecasted Market Size by Region
- 4.3.1 Global Amoxicillin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Amoxicillin Sales in Value by Region (2027-2032)
- 4.3.3 Global Amoxicillin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amoxicillin by Application
- 5.1 Amoxicillin Market by Application
- 5.1.1 Hospital Pharmacy
- 5.1.2 Retail Pharmacy
- 5.1.3 Online Pharmacy
- 5.2 Global Amoxicillin Market Size by Application
- 5.2.1 Global Amoxicillin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Amoxicillin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Amoxicillin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Amoxicillin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Amoxicillin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Amoxicillin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Amoxicillin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Amoxicillin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 GSK
- 6.1.1 GSK Company Information
- 6.1.2 GSK Business Overview
- 6.1.3 GSK Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 GSK Amoxicillin Product Portfolio
- 6.1.5 GSK Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Company Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Novartis Amoxicillin Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Centrient Pharma
- 6.3.1 Centrient Pharma Company Information
- 6.3.2 Centrient Pharma Business Overview
- 6.3.3 Centrient Pharma Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Centrient Pharma Amoxicillin Product Portfolio
- 6.3.5 Centrient Pharma Recent Developments
- 6.4 Teva
- 6.4.1 Teva Company Information
- 6.4.2 Teva Business Overview
- 6.4.3 Teva Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Teva Amoxicillin Product Portfolio
- 6.4.5 Teva Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Mylan Amoxicillin Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Cipla
- 6.6.1 Cipla Company Information
- 6.6.2 Cipla Business Overview
- 6.6.3 Cipla Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Cipla Amoxicillin Product Portfolio
- 6.6.5 Cipla Recent Developments
- 6.7 NCPC
- 6.7.1 NCPC Company Information
- 6.7.2 NCPC Business Overview
- 6.7.3 NCPC Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 NCPC Amoxicillin Product Portfolio
- 6.7.5 NCPC Recent Developments
- 6.8 United Laboratories
- 6.8.1 United Laboratories Company Information
- 6.8.2 United Laboratories Business Overview
- 6.8.3 United Laboratories Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 United Laboratories Amoxicillin Product Portfolio
- 6.8.5 United Laboratories Recent Developments
- 6.9 Sun Pharma
- 6.9.1 Sun Pharma Company Information
- 6.9.2 Sun Pharma Business Overview
- 6.9.3 Sun Pharma Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sun Pharma Amoxicillin Product Portfolio
- 6.9.5 Sun Pharma Recent Developments
- 6.10 CSPC
- 6.10.1 CSPC Company Information
- 6.10.2 CSPC Business Overview
- 6.10.3 CSPC Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 CSPC Amoxicillin Product Portfolio
- 6.10.5 CSPC Recent Developments
- 6.11 LKPC
- 6.11.1 LKPC Company Information
- 6.11.2 LKPC Business Overview
- 6.11.3 LKPC Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 LKPC Amoxicillin Product Portfolio
- 6.11.5 LKPC Recent Developments
- 6.12 Hikma
- 6.12.1 Hikma Company Information
- 6.12.2 Hikma Business Overview
- 6.12.3 Hikma Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Hikma Amoxicillin Product Portfolio
- 6.12.5 Hikma Recent Developments
- 6.13 Dr. Reddy
- 6.13.1 Dr. Reddy Company Information
- 6.13.2 Dr. Reddy Business Overview
- 6.13.3 Dr. Reddy Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Dr. Reddy Amoxicillin Product Portfolio
- 6.13.5 Dr. Reddy Recent Developments
- 6.14 HPGC
- 6.14.1 HPGC Company Information
- 6.14.2 HPGC Business Overview
- 6.14.3 HPGC Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 HPGC Amoxicillin Product Portfolio
- 6.14.5 HPGC Recent Developments
- 6.15 Aurubindo
- 6.15.1 Aurubindo Company Information
- 6.15.2 Aurubindo Business Overview
- 6.15.3 Aurubindo Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Aurubindo Amoxicillin Product Portfolio
- 6.15.5 Aurubindo Recent Developments
- 6.16 Meiji Holdings
- 6.16.1 Meiji Holdings Company Information
- 6.16.2 Meiji Holdings Business Overview
- 6.16.3 Meiji Holdings Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Meiji Holdings Amoxicillin Product Portfolio
- 6.16.5 Meiji Holdings Recent Developments
7 North America by Country
- 7.1 North America Amoxicillin Sales by Country
- 7.1.1 North America Amoxicillin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Amoxicillin Sales by Country (2021-2026)
- 7.1.3 North America Amoxicillin Sales Forecast by Country (2027-2032)
- 7.2 North America Amoxicillin Market Size by Country
- 7.2.1 North America Amoxicillin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Amoxicillin Market Size by Country (2021-2026)
- 7.2.3 North America Amoxicillin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Amoxicillin Sales by Country
- 8.1.1 Europe Amoxicillin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Amoxicillin Sales by Country (2021-2026)
- 8.1.3 Europe Amoxicillin Sales Forecast by Country (2027-2032)
- 8.2 Europe Amoxicillin Market Size by Country
- 8.2.1 Europe Amoxicillin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Amoxicillin Market Size by Country (2021-2026)
- 8.2.3 Europe Amoxicillin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Amoxicillin Sales by Country
- 9.1.1 Asia-Pacific Amoxicillin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Amoxicillin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Amoxicillin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Amoxicillin Market Size by Country
- 9.2.1 Asia-Pacific Amoxicillin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Amoxicillin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Amoxicillin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Amoxicillin Sales by Country
- 10.1.1 South America Amoxicillin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Amoxicillin Sales by Country (2021-2026)
- 10.1.3 South America Amoxicillin Sales Forecast by Country (2027-2032)
- 10.2 South America Amoxicillin Market Size by Country
- 10.2.1 South America Amoxicillin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Amoxicillin Market Size by Country (2021-2026)
- 10.2.3 South America Amoxicillin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Amoxicillin Sales by Country
- 11.1.1 Middle East and Africa Amoxicillin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Amoxicillin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Amoxicillin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Amoxicillin Market Size by Country
- 11.2.1 Middle East and Africa Amoxicillin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Amoxicillin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Amoxicillin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Amoxicillin Value Chain Analysis
- 12.1.1 Amoxicillin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Amoxicillin Production Mode & Process
- 12.2 Amoxicillin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Amoxicillin Distributors
- 12.2.3 Amoxicillin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst